SuperPain - A resource on pain-relieving compounds targeting ion channels

Nucleic Acids Research

Volumn 42, Issue D1, 2014, Pages

  Gohlke, Björn O ^a   Preissner, Robert ^b   Preissner, Saskia ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACID SENSING ION CHANNEL; ANALGESIC AGENT; ION CHANNEL; POTASSIUM CHANNEL HERG; PURINERGIC P2X RECEPTOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; TREK1 PROTEIN; TWIK RELATED SPINAL CORD POTASSIUM CHANNEL; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VOLTAGE GATED SODIUM CHANNEL; LIGAND; POTASSIUM CHANNEL; PROTEIN TREK1; PROTEIN TRESK;

ARTICLE; BINDING AFFINITY; CLUSTER ANALYSIS; COMPUTER INTERFACE; DRUG DATABASE; LIGAND BINDING; MOLECULAR DOCKING; NOCICEPTION; PRIORITY JOURNAL; PROTEIN STRUCTURE; SUPERPAIN DATABASE; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICAL DATABASE; CHEMISTRY; HUMAN; INTERNET; STRUCTURAL HOMOLOGY; CENTRAL NERVOUS SYSTEM; DRUG BINDING SITE; DRUG DESIGN; DRUG RESEARCH; DRUG TARGETING; INFORMATION PROCESSING; NEUROTRANSMISSION;

ANALGESICS; ANIMALS; DATABASES, CHEMICAL; HUMANS; INTERNET; ION CHANNELS; LIGANDS; STRUCTURAL HOMOLOGY, PROTEIN;

EID: 84891772177     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt1176     Document Type: Article

References (38)

1. Montell, C., Birnbaumer, L., Flockerzi, V., Bindels, R.J., Bruford, E.A., Caterina, M.J., Clapham, D.E., Harteneck, C., Heller, S., Julius, D. et al. (2002) A unified nomenclature for the superfamily of TRP cation channels. Mol. Cell, 9, 229-231.
2. Schwartz, E.S., La, J.H., Scheff, N.N., Davis, B.M., Albers, K.M. and Gebhart, G.F. (2013) TRPV1 and TRPA1 antagonists prevent the transition of acute to chronic inflammation and pain in chronic pancreatitis. J. Neurosci., 33, 5603-5611.
3. Lebovitz, E.E., Keller, J.M., Kominsky, H., Kaszas, K., Maric, D. and Iadarola, M.J. (2012) Positive allosteric modulation of TRPV1 as a novel analgesic mechanism. Mol. Pain, 8, 70.
4. Premkumar, L.S. and Abooj, M. (2013) TRP channels and analgesia. Life Sci., 92, 415-424.
5. Bharate, S.S. and Bharate, S.B. (2012) Modulation of thermoreceptor TRPM8 by cooling compounds. ACS Chem. Neurosci., 3, 248-267.
6. Selescu, T., Ciobanu, A.C., Dobre, C., Reid, G. and Babes, A. (2013) Camphor activates and sensitizes transient receptor potential melastatin 8 (TRPM8) to cooling and icilin. Chem. Senses., 38, 563-575.
7. Journigan, V.B. and Zaveri, N.T. (2013) TRPM8 ion channel ligands for new therapeutic applications and as probes to study menthol pharmacology. Life Sci., 92, 425-437.
8. Storey, D.J., Colvin, L.A., Mackean, M.J., Mitchell, R., Fleetwood-Walker, S.M. and Fallon, M.T. (2010) Reversal of dose-limiting carboplatin-induced peripheral neuropathy with TRPM8 activator, menthol, enables further effective chemotherapy delivery. J. Pain Symptom. Manage., 39, e2-e4.
9. Docherty, R.J., Ginsberg, L., Jadoon, S., Orrell, R.W. and Bhattacharjee, A. (2013) TRPA1 insensitivity of human sural nerve axons after exposure to lidocaine. Pain, 154, 1569-1577.
10. Nativi, C., Gualdani, R., Dragoni, E., Di Cesare Mannelli, L., Sostegni, S., Norcini, M., Gabrielli, G., la Marca, G., Richichi, B., Francesconi, O. et al. (2013) A TRPA1 antagonist reverts oxaliplatin-induced neuropathic pain. Sci. Rep., 3, 2005.
11. Thomas, D., Karle, C.A. and Kiehn, J. (2006) The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications. Curr. Pharm. Des., 12, 2271-2283.
12. Stary, A., Wacker, S.J., Boukharta, L., Zachariae, U., Karimi-Nejad, Y., Aqvist, J., Vriend, G. and de Groot, B.L. (2010) Toward a consensus model of the HERG potassium channel. Chem. Med. Chem., 5, 455-467.
13. Durdagi, S., Deshpande, S., Duff, H.J. and Noskov, S.Y. (2012) Modeling of open, closed, and open-inactivated states of the hERG1 channel: structural mechanisms of the state-dependent drug binding. J. Chem. Inf. Model, 52, 2760-2774.
14. Rayan, A., Falah, M., Raiyn, J., Da'adoosh, B., Kadan, S., Zaid, H. and Goldblum, A. (2013) Indexing molecules for their hERG liability. Eur. J. Med. Chem., 65C, 304-314.
15. Fischer, T.Z. and Waxman, S.G. (2010) Familial pain syndromes from mutations of the NaV1.7 sodium channel. Ann. N. Y. Acad. Sci., 1184, 196-207.
16. Hilder, T.A. and Chung, S.H. (2013) Designing a C84 fullerene as a specific voltage-gated sodium channel blocker. Nanoscale Res. Lett., 8, 323.
17. Gallin, W.J. and Boutet, P.A. (2011) VKCDB: voltage-gated K+ channel database updated and upgraded. Nucleic Acids Res., 39, D362-D366.
18. Shin, Y.C., Shin, S.Y., Chun, J.N., Cho, H.S., Lim, J.M., Kim, H.G., So, I., Kwon, D. and Jeon, J.H. (2012) TRIP database 2.0: a manually curated information hub for accessing TRP channel interaction network. PLoS One, 7, e47165.
19. Berka, K., Hanak, O., Sehnal, D., Banas, P., Navratilova, V., Jaiswal, D., Ionescu, C.M., Svobodova Varekova, R., Koca, J. and Otyepka, M. (2012) MOLEonline 2.0: interactive web-based analysis of biomacromolecular channels. Nucleic Acids Res., 40, W222-W227.
20. Sharman, J.L., Benson, H.E., Pawson, A.J., Lukito, V., Mpamhanga, C.P., Bombail, V., Davenport, A.P., Peters, J.A., Spedding, M. and Harmar, A.J. (2013) IUPHAR-DB: updated database content and new features. Nucleic Acids Res., 41, D1083-D1088.
21. Wang, Y., Bolton, E., Dracheva, S., Karapetyan, K., Shoemaker, B.A., Suzek, T.O., Wang, J., Xiao, J., Zhang, J. and Bryant, S.H. (2010) An overview of the PubChem BioAssay resource. Nucleic Acids Res., 38, D255-D266.
22. Liu, T., Lin, Y., Wen, X., Jorissen, R.N. and Gilson, M.K. (2007) BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res., 35, D198-D201.
23. Bhat, T.N., Bourne, P., Feng, Z., Gilliland, G., Jain, S., Ravichandran, V., Schneider, B., Schneider, K., Thanki, N., Weissig, H. et al. (2001) The PDB data uniformity project. Nucleic Acids Res., 29, 214-218.
24. Prlic, A., Bliven, S., Rose, P.W., Bluhm, W.F., Bizon, C., Godzik, A. and Bourne, P.E. (2010) Pre-calculated protein structure alignments at the RCSB PDB website. Bioinformatics, 26, 2983-2985.
25. Laskowski, R.A. and Swindells, M.B. (2011) LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model, 51, 2778-2786.
26. Fernandez-Ballester, G. and Ferrer-Montiel, A. (2008) Molecular modeling of the full-length human TRPV1 channel in closed and desensitized states. J. Membr. Biol., 223, 161-172.
27. Jasti, J., Furukawa, H., Gonzales, E.B. and Gouaux, E. (2007) Structure of acid-sensing ion channel 1 at 1.9 A resolution and low pH. Nature, 449, 316-323.
28. Diochot, S., Baron, A., Salinas, M., Douguet, D., Scarzello, S., Dabert-Gay, A.S., Debayle, D., Friend, V., Alloui, A., Lazdunski, M. et al. (2012) Black mamba venom peptides target acid-sensing ion channels to abolish pain. Nature, 490, 552-555.
29. Pietra, F. (2012) Putative binding sites, and pathways to them, for amidine and guanidine current inhibitors on acid-sensing ion channels (ASIC). A theoretical approach with hASIC1a homology model. Chem. Biodivers., 9, 331-351.
30. North, R.A. and Jarvis, M.F. (2013) P2X receptors as drug targets. Mol. Pharmacol., 83, 759-769.
31. Enyedi, P., Braun, G. and Czirjak, G. (2012) TRESK: the lone ranger of two-pore domain potassium channels. Mol. Cell Endocrinol., 353, 75-81.
32. Lafreniere, R.G. and Rouleau, G.A. (2011) Migraine: role of the TRESK two-pore potassium channel. Int. J. Biochem. Cell Biol., 43, 1533-1536.
33. Alloui, A., Zimmermann, K., Mamet, J., Duprat, F., Noel, J., Chemin, J., Guy, N., Blondeau, N., Voilley, N., Rubat-Coudert, C. et al. (2006) TREK-1, a K+ channel involved in polymodal pain perception. Embo J., 25, 2368-2376.
34. Messeguer, A., Planells-Cases, R. and Ferrer-Montiel, A. (2006) Physiology and pharmacology of the vanilloid receptor. Curr. Neuropharmacol., 4, 1-15.
35. Cascio, M.G., Gauson, L.A., Stevenson, L.A., Ross, R.A. and Pertwee, R.G. (2010) Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist. Br. J. Pharmacol., 159, 129-141.
36. Colasanti, B.K., Craig, C.R. and Allara, R.D. (1984) Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol. Exp. Eye Res., 39, 251-259.
37. Borrelli, F., Fasolino, I., Romano, B., Capasso, R., Maiello, F., Coppola, D., Orlando, P., Battista, G., Pagano, E., Di Marzo, V. et al. (2013) Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. Biochem. Pharmacol., 85, 1306-1316.
38. De Petrocellis, L., Vellani, V., Schiano-Moriello, A., Marini, P., Magherini, P.C., Orlando, P. and Di Marzo, V. (2008) Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. J. Pharmacol. Exp. Ther., 325, 1007-1015.